BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 17603319)

  • 1. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
    Kim HH; Addison J; Suh E; Trune DR; Richter CP
    Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy.
    Addison J; Kim HH; Richter CP
    Laryngoscope; 2006 Feb; 116(2):279-82. PubMed ID: 16467719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
    Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
    Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis.
    Worsøe L; Brandt CT; Lund SP; Ostergaard C; Thomsen J; Cayé-Thomasen P
    Otol Neurotol; 2010 Apr; 31(3):394-403. PubMed ID: 20147868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of post-meningitic cochlear injury with cerebrospinal fluid irrigation.
    Yeung AH; Tinling SP; Brodie HA
    Otolaryngol Head Neck Surg; 2006 Feb; 134(2):214-24. PubMed ID: 16455367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase.
    Ge NN; Brodie HA; Tinling SP
    Otol Neurotol; 2008 Dec; 29(8):1061-7. PubMed ID: 18849884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of superoxide dismutase in gerbils with bacterial meningitis.
    Ge NN; Brodie SA; Tinling SP; Brodie HA
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):563-72. PubMed ID: 15523427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat.
    Coimbra RS; Loquet G; Leib SL
    Pediatr Res; 2007 Sep; 62(3):291-4. PubMed ID: 17622952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
    Liu X; Han Q; Sun R; Li Z
    Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
    Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
    J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
    Klein M; Koedel U; Pfister HW; Kastenbauer S
    Ann Neurol; 2003 Oct; 54(4):451-8. PubMed ID: 14520656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes.
    Brandt CT; Cayé-Thomasen P; Lund SP; Worsøe L; Ostergaard C; Frimodt-Møller N; Espersen F; Thomsen J; Lundgren JD
    Neurobiol Dis; 2006 Aug; 23(2):300-11. PubMed ID: 16798006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss.
    Vivero RJ; Joseph DE; Angeli S; He J; Chen S; Eshraghi AA; Balkany TJ; Van de Water TR
    Laryngoscope; 2008 Nov; 118(11):2028-35. PubMed ID: 18818553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed electrical stimulation and BDNF application following induced deafness in rats.
    Song BN; Li YX; Han DM
    Acta Otolaryngol; 2009 Feb; 129(2):142-54. PubMed ID: 18607918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis.
    Fernández A; Cabellos C; Tubau F; Maiques JM; Doménech A; Ribes S; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2005 Jan; 55(1):78-83. PubMed ID: 15546968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide concentrations and cerebrospinal fluid parameters in an experimental animal model of Streptococcus pneumoniae meningitis.
    Destache CJ; Pakiz CB; Dash AK; Larsen C
    Pharmacotherapy; 1998; 18(3):612-9. PubMed ID: 9620112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
    Matsuoka AJ; Kondo T; Miyamoto RT; Hashino E
    Laryngoscope; 2007 Sep; 117(9):1629-35. PubMed ID: 17632425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routes, dynamics, and correlates of cochlear inflammation in terminal and recovering experimental meningitis.
    Cayé-Thomasen P; Worsøe L; Brandt CT; Miyazaki H; Ostergaard C; Frimodt-Møller N; Thomsen J
    Laryngoscope; 2009 Aug; 119(8):1560-70. PubMed ID: 19504554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tumor necrosis factor-alpha in sensorineural hearing loss after bacterial meningitis.
    Aminpour S; Tinling SP; Brodie HA
    Otol Neurotol; 2005 Jul; 26(4):602-9. PubMed ID: 16015154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis.
    Klein M; Schmidt C; Kastenbauer S; Paul R; Kirschning CJ; Wagner H; Popp B; Pfister HW; Koedel U
    J Infect Dis; 2007 Apr; 195(8):1189-93. PubMed ID: 17357057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.